Pharmaceuticals · Pharmaceuticals: Major · NSE: REMUS · data 2026-10-30

Remus Pharmaceuticals Ltd.

₹843.35-3.48% on 30 OctHealth: Strong 8.1/10

Feb 2026Low ₹582.85 · High ₹1,020.75+29.7%

In plain words

Price: 18.8% below its 52-week high of ₹1,039.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹843.35

Market cap

₹1,030 cr

P/E

26.9

P/B

2.8

ROE

12.2%

ROCE

14.7%

Debt / equity

0.08

Dividend yield

0.11%

1-year return

27.8%

52-week high

₹1,039

52-week low

₹580

Operating margin

6.3%

Growth

Revenue (last 12 months)	₹854 cr
Net profit (last 12 months)	₹37 cr
Sales growth, 3 years (yearly)	166.6%
Profit growth, 3 years (yearly)	63.2%

Smart-money activity

5/100 · Weak over the last ~60 sessions

Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Remus Pharmaceuticals Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.08, which is very low.

What is Remus Pharmaceuticals Ltd.'s P/E ratio?

About 26.9, based on the last 12 months' earnings and a price of ₹843.35 (data 2026-10-30).

What is the 52-week high and low of Remus Pharmaceuticals Ltd.?

The 52-week high is ₹1,039 and the 52-week low is ₹580.

Similar companies

Bafna Pharmaceuticals Limited (BAFNAPH) · Bajaj Healthcare Ltd (BAJAJHCARE) · Lincoln Pharmaceuticals Ltd (LINCOLN) · Sigachi Industries Limited (SIGACHI) · Sudarshan Pharma Industries Ltd (SUDARSHAN)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open REMUS in NSE Scanner →